4th Quarter - Report

BRYAN CAVE LEIGHTON PAISNER LLP for THE ENDOCRINE SOCIETY

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Fiscal Year 2012 Appropriations for National Institutes of Health H.R. 2020/ S. 1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R. 533 Endocrine Disruptor Screening Enhancement Act of 2011 H.R. 2521/S. 1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011 Medicare Physician Payment Reform Funding for National Diabetes Prevention Program (NDPP)

LobbyistCovered position, as disclosed
WILLIAM APPLEGATE —
CHRISTOPHER RORICK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2020 (112th), H.R. 533 (112th), S. 1096 (112th), S. 1361 (112th), H.R. 2521 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.